Effect Of Statin Therapy In Stroke Patients With Low Baseline Low-density Lipoprotein Cholesterol

被引：0
|
作者：
Kim, Yong Soo
Jeong, Han-gil
Park, Chan-Young
Kim, Museong
Lee, Subin
机构：
来源：
STROKE | 2023年 / 54卷
关键词：
D O I：
10.1161/str.54.suppl_1.TMP104
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
ATMP104
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition
    Marcusa, Daniel P.
    Giugliano, Robert P.
    Park, Jeong-Gun
    de Lemos, James A.
    Cannon, Christopher P.
    Sabatine, Marc S.
    JAMA CARDIOLOGY, 2021, 6 (05) : 582 - 586
  • [32] Statin therapy and reductions in low-density lipoprotein cholesterol: Initial clinical data on the potent new statin rosuvastatin
    Olsson, AG
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (5A): : 33B - 36B
  • [33] Effectiveness of statin therapy for elderly acute myocardial infarction patients with normal levels of low-density lipoprotein cholesterol
    Yamanaka, Futoshi
    Jeong, Myung Ho
    Saito, Shigeru
    Ahn, Youngkeun
    Chae, Shung Chull
    Hur, Seung Ho
    Hong, Taek Jong
    Kim, Young Jo
    Seong, In Whan
    Chae, Jei Keon
    Rhew, Jay Young
    Chae, In Ho
    Cho, Myeong Chan
    Bae, Jang Ho
    Rha, Seung Woon
    Kim, Chong Jin
    Choi, Donghoon
    Jang, Yang Soo
    Yoon, Junghan
    Chung, Wook Sung
    Cho, Jeong Gwan
    Seung, Ki Bae
    Park, Seung Jung
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (01) : 139 - 143
  • [34] Effect of Low-density Lipoprotein Cholesterol Lowering With Alirocumab on Stroke in ODYSSEY OUTCOMES
    Jukema, J. Wouter
    Szarek, Michael
    Zijlstra, Laurien
    Bhatt, Deepak L.
    Bittner, Vera A.
    Diaz, Rafael
    Drexel, Heinz
    Goodman, Shaun G.
    Harrington, Robert A.
    Kim, Yong-Un
    Louie, Michael J.
    Pordy, Robert
    Reiner, Zeljko
    Roe, Matthew T.
    Tse, Hung-Fat
    Valdovinos, Pablo Carlos Montenegro
    White, Harvey D.
    Zeiher, Andreas M.
    Schwartz, Gregory G.
    Steg, Philippe G.
    CIRCULATION, 2019, 140
  • [35] Addition of ezetimibe to ongoing statin therapy: incremental reduction in low-density lipoprotein cholesterol is independent of statin type
    Mata, P
    Gumbiner, B
    Musliner, T
    Quinto, K
    Cho, M
    EUROPEAN HEART JOURNAL, 2002, 23 : 19 - 19
  • [36] Ezetimibe added to ongoing statin therapy:: Incremental reductions in low-density lipoprotein cholesterol are independent of statin efficacy
    Mata, P
    Roth, E
    Masana, L
    Pintó, X
    Troxell, J
    Allen, C
    Gumbiner, B
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 135 - 135
  • [37] Modification of Statin Therapy on the Relationship of Low-density Lipoprotein Cholesterol With Incident CKD in Us Veterans
    Hsiung, Jui-Ting
    Marroquin, Maria
    Kalantar-Zadeh, Kamyar
    CIRCULATION, 2020, 142
  • [38] Initial low-density, lipoprotein response to statin therapy predicts subsequent low-density lipoprotein response to the addition of Ezetimibe
    Ziajka, PE
    Reis, M
    Kreul, S
    King, H
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (06): : 779 - 780
  • [39] The safety of aggressive statin therapy: How much can low-density lipoprotein cholesterol be lowered?
    Jacobson, Terry A.
    MAYO CLINIC PROCEEDINGS, 2006, 81 (09) : 1225 - 1231
  • [40] Statin and ezetimibe combination therapy: New therapeutic options for lowering Low-Density Lipoprotein Cholesterol
    Lin, Xiao-Long
    Liu, Mi-Hua
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 247 : 49 - 49
12345